Advertisement

Topics

Latest Brain Cancer NewsRSS

04:28 EST 17th February 2019 | BioPortfolio

'Cellular Barcoding' Reveals How Breast Cancer Spreads

NewsA cutting-edge technique called cellular barcoding has been used to tag, track and pinpoint cells responsible for the spread of breast cancer.

Hereditary Prostate Cancer—What Urologists Should Know

Historically, urologists have been the primary caretakers for men with localized prostate cancer, which is the most prevalent solid tumor in men over 50 years of age and the second-leading cause of cancer-specific mortality in the United States today.

Medullary Thyroid Cancer – Pipeline Insight, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Medullary Thyroid Cancer – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Medullary Thyroid Cancer – Pipeline Insight, 2019 offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Medullary Thyroid … Continue reading &#...

STAT Plus: Medicare would provide national coverage for CAR-T cancer therapies under new proposal

Under a new proposal, the Medicare program would pay for expensive new cancer therapies known as CAR-T, for patients across the country.

Cancer Cells May Have Achilles’ Heel in Cholesterol

A rare tumor type of cancer is unable to synthesize cholesterol, opening the door to an entirely new way of approaching treatment. The post Cancer Cells May Have Achilles’ Heel in Cholesterol appeared first on GEN - Genetic Engineering and Biotechnology News.

Artificial Intelligence Improves Ovarian Cancer Prognosis

Scientists at Imperial College London and the University of Melbourne have developed artificial intelligence (AI) software that they claim can more accurately predict ovarian cancer prognosis than current methods, and which can also indicate which treatments are most likely to be effective for individual patients. The post Artificial Intelligence Improves Ovarian Cancer Prognosis appeared first on...

University of Minnesota to offer new targeted therapy for recurrent brain tumors

GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors. The first patient was treated by The post University of Minnesota to offer new targeted therapy for recurrent brain tumors appeared first on Compelo Medical Devices.

More cancer patients are living longer, studies show. But few are getting the help they need to stay healthy https://www.usatoday.com/in-depth/news/50-states/2019/02/13/life-after-cancer-survivors-oncology-survivorship-plans-long-term-health/2794121002/ 

More cancer patients are living longer, studies show. But few are getting the help they need to stay healthy https://www.usatoday.com/in-depth/news/50-states/2019/02/13/life-after-cancer-survivors-oncology-survivorship-plans-long-term-health/2794121002/ …

New prostate cancer data puts Bayer drug in line with Pfizer, J&J rivals

Pfizer and J&J are already on the market with products for non-metastatic prostate cancer. Bayer aims to compete with its drug darolutamide.

Stitching together a 'Google Earth' for cancer - Cancer Research UK https://scienceblog.cancerresearchuk.org/2019/02/14/stitching-together-a-google-earth-for-cancer/ …

Stitching together a 'Google Earth' for cancer - Cancer Research UK https://scienceblog.cancerresearchuk.org/2019/02/14/stitching-together-a-google-earth-for-cancer/ …

Registration is Now Open for the 2019 Targeted Therapies Live Patient Forum

Join GRACE Live in Philadelphia for the 2019 Targeted Therapies Patient ForumDenise Brock, Operations Director

February 15 Research Roundup: Rare Pediatric Cancer, Hibernating Hamsters, Prostate Cancer and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer

Although parity and age at first pregnancy are among the most known extrinsic factors that modulate breast cancer risk, their impact on the biology of subsequent breast cancer has never been explored in depth....

The #BirsoyLab, led by @KivancBirsoy, has identified a rare type of #cancer cell that cannot make cholesterol, a key nutrient. By targeting this deficiency, scientists may be able to develop new strategies for treating the disease. https://www.rockefeller

The #BirsoyLab, led by @KivancBirsoy, has identified a rare type of #cancer cell that cannot make cholesterol, a key nutrient. By targeting this deficiency, scientists may be able to develop new strategies for treating the disease. https://www.rockefeller.edu/news/251

KIDNEY FAILURE PATIENTS FACE HIGHER RISK OF CANCER DEATH

In a population-based study, both patients on dialysis and those who received kidney transplants experienced over 2.5-times higher risks of cancer death than age- and sex-matched individuals without kidney failure. In dialysis patients, the main driver for cancer death was from cancers that were present prior to starting dialysis, whereas in transplant recipients, cancer deaths were mainly driven...

Finasteride Safe and Effective in Prostate Cancer Prevention

The 5α-reductase inhibitor finasteride (Proscar), an agent commonly used to treat lower urinary tract problems and baldness in men, was found to be safe and effective in reducing the risk of prostate cancer.

Novel Agents Spark New Approaches for Triple-Negative Breast Cancer

During a recent OncLive Peer Exchange®, a panel of breast cancer experts discussed emerging agents in triple-negative breast cancer, which include an anti–PD-L1 antibody, 2 PARP inhibitors, and a novel antibody–drug conjugate.

Mexico Neuromodulation Procedures Outlook to 2025 [Report Updated: 15112018] Prices from USD $2995

Mexico Neuromodulation Procedures Outlook to 2025SummaryGlobalData's new report, Mexico Neuromodulation Procedures Outlook to 2025, provides key procedures data on the Mexico Neuromodulation Procedures. The report provides procedure volumes within market segments Deep Brain Stimulators Procedures, Gastric Electric Stimulators Procedures, Peripheral Nerve Stimulators Procedures, Sacral Nerve Stimu...

Research shows damage depression inflicts on brain

Condition affects cognitive function and memory that scientists have linked to dementia

Brahmer Calls for Better Incorporation of Precision Medicine in Lung Cancer

Julie R. Brahmer, MD, discusses advances made with immunotherapy in the lung cancer space, highlights challenges that still need to be addressed, and sheds light on ongoing research designed to determine treatment approaches beyond PD-1/PD-L1 and CTLA-4 inhibition

A Trojan Horse Approach to Cancer

A research team led by Professor Johann de B

Checkpoint Inhibitor Levels for Lung Cancer Rapidly Measured with New Tool

Assessing the level of programmed death ligand 1 (PD-L1) expressed by a non–small-cell lung (NSCLC) tumor can help clinicians determine how the patient should be treated. Now, researchers report (“A Novel Approach to Detect Programmed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy Specimen”) in the […] The pos...

Cancer Spread and Blood Clots May Be Halted by Platelet Decoys

Blood platelets play a critical role in helping blood to clot and stop bleeding after injury. However, activated platelets can also contribute to the formation of unwanted, dangerous blood clots, and are associated with a range of disorders, including cancer. Although antiplatelet therapies are available to help address platelet-related disorders, treated patients are then at […] The post Ca...

Zebra Medical Vision is Granted Three Israeli Government Grants to Deploy Medical Imaging AI at Scale

Zebra Medical Vision announces it’s the recipient of three grants from the Israeli innovation authority to provide AI analysis at Ichilov Hospital, and through Integrated health providers Maccabi and Clalit. Zebra Medical Vision (https://www.zebra

Active Surveillance Is Becoming More Common for Men with Low-Risk Prostate Cancer

For high-risk cancer, therapy is shifting from radiotherapy to radical prostatectomy.

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Brain Cancer market research data and corporate reports here